Ablynx

Ablynx

Ablynx

Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies® for a range of serious human diseases.
Founded
2001
Raised
$372.6M
Follow us
Alexa global traffic share
Twitter followers
Team Size
200+
Employees
Location
Headquarters
Past year's investments

Ablynx participated in fewer than 3 rounds over the past year